Supplemental oxygen strategies in infants with bronchopulmonary dysplasia after the neonatal intensive care unit period: study protocol for a randomised controlled trial (SOS BPD study)

Introduction Supplemental oxygen is the most important treatment for preterm born infants with established bronchopulmonary dysplasia (BPD). However, it is unknown what oxygen saturation levels are optimal to improve outcomes in infants with established BPD from 36 weeks postmenstrual age (PMA) onwa...

Full description

Saved in:
Bibliographic Details
Main Authors: Anton H van Kaam, Wes Onland, Irwin K M Reiss, Peter H Dijk, Arend F Bos, Eleni-Rosalina Andrinopoulou, E Villamor, LGM van Rooij, M de Jong, JS von Lindern, Lucas Goossens, Stephanie Balink, Elianne J L E Vrijlandt, Anthon R Hulsmann, Debbie H Nuytemans, Arwen J Sprij, André A Kroon, Marielle Pijnenburg, MGA Baartmans, GJ Blok, WP de Boode, HD Buiter, CE Counsilman, CA Dalen Meurs, ACM Dassel, AM de Grauw, MEN van den Heuvel, JLAM van Hillegersberg, JCR van Hoften, JHL van Hoorn, CH ten Hove, A Kamerbeek, AAMW van Kempen, LH van der Meer, RMJ Moonen, EEM Mulder, HJ Niemarkt, MAG van Scherpenzeel-de Vries, IAM Schiering, RNGB Tan
Format: Article
Language:English
Published: BMJ Publishing Group 2022-07-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/7/e060986.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832576062824906752
author Anton H van Kaam
Wes Onland
Irwin K M Reiss
Peter H Dijk
Arend F Bos
Eleni-Rosalina Andrinopoulou
E Villamor
LGM van Rooij
M de Jong
JS von Lindern
Lucas Goossens
Stephanie Balink
Elianne J L E Vrijlandt
Anthon R Hulsmann
Debbie H Nuytemans
Arwen J Sprij
André A Kroon
Marielle Pijnenburg
MGA Baartmans
GJ Blok
WP de Boode
HD Buiter
CE Counsilman
CA Dalen Meurs
ACM Dassel
AM de Grauw
MEN van den Heuvel
JLAM van Hillegersberg
JCR van Hoften
JHL van Hoorn
CH ten Hove
A Kamerbeek
AAMW van Kempen
LH van der Meer
RMJ Moonen
EEM Mulder
HJ Niemarkt
MAG van Scherpenzeel-de Vries
IAM Schiering
RNGB Tan
author_facet Anton H van Kaam
Wes Onland
Irwin K M Reiss
Peter H Dijk
Arend F Bos
Eleni-Rosalina Andrinopoulou
E Villamor
LGM van Rooij
M de Jong
JS von Lindern
Lucas Goossens
Stephanie Balink
Elianne J L E Vrijlandt
Anthon R Hulsmann
Debbie H Nuytemans
Arwen J Sprij
André A Kroon
Marielle Pijnenburg
MGA Baartmans
GJ Blok
WP de Boode
HD Buiter
CE Counsilman
CA Dalen Meurs
ACM Dassel
AM de Grauw
MEN van den Heuvel
JLAM van Hillegersberg
JCR van Hoften
JHL van Hoorn
CH ten Hove
A Kamerbeek
AAMW van Kempen
LH van der Meer
RMJ Moonen
EEM Mulder
HJ Niemarkt
MAG van Scherpenzeel-de Vries
IAM Schiering
RNGB Tan
author_sort Anton H van Kaam
collection DOAJ
description Introduction Supplemental oxygen is the most important treatment for preterm born infants with established bronchopulmonary dysplasia (BPD). However, it is unknown what oxygen saturation levels are optimal to improve outcomes in infants with established BPD from 36 weeks postmenstrual age (PMA) onwards. The aim of this study is to compare the use of a higher oxygen saturation limit (≥95%) to a lower oxygen saturation limit (≥90%) after 36 weeks PMA in infants diagnosed with moderate or severe BPD.Methods and analysis This non-blinded, multicentre, randomised controlled trial will recruit 198 preterm born infants with moderate or severe BPD between 36 and 38 weeks PMA. Infants will be randomised to either a lower oxygen saturation limit of 95% or to a lower limit of 90%; supplemental oxygen and/or respiratory support will be weaned based on the assigned lower oxygen saturation limit. Adherence to the oxygen saturation limit will be assessed by extracting oxygen saturation profiles from pulse oximeters regularly, until respiratory support is stopped. The primary outcome is the weight SD score at 6 months of corrected age. Secondary outcomes include anthropometrics collected at 6 and 12 months of corrected age, rehospitalisations, respiratory complaints, infant stress, parental quality of life and cost-effectiveness.Ethics and dissemination Ethical approval for the trial was obtained from the Medical Ethics Review Committee of the Erasmus University Medical Centre, Rotterdam, the Netherlands (MEC-2018–1515). Local approval for conducting the trial in the participating hospitals has been or will be obtained from the local institutional review boards. Informed consent will be obtained from the parents or legal guardians of all study participants.Trial registration number NL7149/NTR7347.
format Article
id doaj-art-9c04d4fed3754a7abd7a45fc38904e55
institution Kabale University
issn 2044-6055
language English
publishDate 2022-07-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-9c04d4fed3754a7abd7a45fc38904e552025-01-31T13:30:09ZengBMJ Publishing GroupBMJ Open2044-60552022-07-0112710.1136/bmjopen-2022-060986Supplemental oxygen strategies in infants with bronchopulmonary dysplasia after the neonatal intensive care unit period: study protocol for a randomised controlled trial (SOS BPD study)Anton H van Kaam0Wes Onland1Irwin K M Reiss2Peter H Dijk3Arend F Bos4Eleni-Rosalina Andrinopoulou5E VillamorLGM van RooijM de JongJS von LindernLucas Goossens6Stephanie Balink7Elianne J L E Vrijlandt8Anthon R Hulsmann9Debbie H Nuytemans10Arwen J Sprij11André A Kroon12Marielle Pijnenburg13MGA BaartmansGJ BlokWP de BoodeHD BuiterCE CounsilmanCA Dalen MeursACM DasselAM de GrauwMEN van den HeuvelJLAM van HillegersbergJCR van HoftenJHL van HoornCH ten HoveA KamerbeekAAMW van KempenLH van der MeerRMJ MoonenEEM MulderHJ NiemarktMAG van Scherpenzeel-de VriesIAM SchieringRNGB Tan3 Amsterdam University Medical Centers, Amsterdam, The NetherlandsAmsterdam UMC Locatie AMC, Amsterdam, The NetherlandsDivision of Neonatology, Department of Paediatrics, Erasmus MC University Medical Center, Rotterdam, The NetherlandsDepartment of Paediatrics, Division of Neonatology, UMCG, Groningen, The NetherlandsDepartment of Paediatrics, Division of Neonatology, UMCG, Groningen, The Netherlands15 Department of Biostatistics, Department of Epidemiology, Erasmus Medical Center, Rotterdam, The NetherlandsErasmus School of Health Policy and Management, Erasmus Universiteit Rotterdam, Rotterdam, The NetherlandsDepartment of Paediatrics/Paediatric Respiratory Medicine, Erasmus MC Sophia Children Hospital, Rotterdam, The NetherlandsDepartment of Paediatrics, Division of Paediatric Pulmonology and Allergology, UMCG, Groningen, The NetherlandsDepartment of Paediatrics, Amphia Hospital, Breda, The NetherlandsDepartment of Paediatrics, Division of Neonatology, Amsterdam UMC Locatie AMC, Amsterdam, The NetherlandsDepartment of Paediatrics, Haga Hospital, Den Haag, The NetherlandsDepartment of Paediatrics, Division of Neonatology, Erasmus MC Sophia Children Hospital, Rotterdam, The NetherlandsDepartment of Paediatrics/Paediatric Respiratory Medicine, Erasmus MC Sophia Children Hospital, Rotterdam, The NetherlandsIntroduction Supplemental oxygen is the most important treatment for preterm born infants with established bronchopulmonary dysplasia (BPD). However, it is unknown what oxygen saturation levels are optimal to improve outcomes in infants with established BPD from 36 weeks postmenstrual age (PMA) onwards. The aim of this study is to compare the use of a higher oxygen saturation limit (≥95%) to a lower oxygen saturation limit (≥90%) after 36 weeks PMA in infants diagnosed with moderate or severe BPD.Methods and analysis This non-blinded, multicentre, randomised controlled trial will recruit 198 preterm born infants with moderate or severe BPD between 36 and 38 weeks PMA. Infants will be randomised to either a lower oxygen saturation limit of 95% or to a lower limit of 90%; supplemental oxygen and/or respiratory support will be weaned based on the assigned lower oxygen saturation limit. Adherence to the oxygen saturation limit will be assessed by extracting oxygen saturation profiles from pulse oximeters regularly, until respiratory support is stopped. The primary outcome is the weight SD score at 6 months of corrected age. Secondary outcomes include anthropometrics collected at 6 and 12 months of corrected age, rehospitalisations, respiratory complaints, infant stress, parental quality of life and cost-effectiveness.Ethics and dissemination Ethical approval for the trial was obtained from the Medical Ethics Review Committee of the Erasmus University Medical Centre, Rotterdam, the Netherlands (MEC-2018–1515). Local approval for conducting the trial in the participating hospitals has been or will be obtained from the local institutional review boards. Informed consent will be obtained from the parents or legal guardians of all study participants.Trial registration number NL7149/NTR7347.https://bmjopen.bmj.com/content/12/7/e060986.full
spellingShingle Anton H van Kaam
Wes Onland
Irwin K M Reiss
Peter H Dijk
Arend F Bos
Eleni-Rosalina Andrinopoulou
E Villamor
LGM van Rooij
M de Jong
JS von Lindern
Lucas Goossens
Stephanie Balink
Elianne J L E Vrijlandt
Anthon R Hulsmann
Debbie H Nuytemans
Arwen J Sprij
André A Kroon
Marielle Pijnenburg
MGA Baartmans
GJ Blok
WP de Boode
HD Buiter
CE Counsilman
CA Dalen Meurs
ACM Dassel
AM de Grauw
MEN van den Heuvel
JLAM van Hillegersberg
JCR van Hoften
JHL van Hoorn
CH ten Hove
A Kamerbeek
AAMW van Kempen
LH van der Meer
RMJ Moonen
EEM Mulder
HJ Niemarkt
MAG van Scherpenzeel-de Vries
IAM Schiering
RNGB Tan
Supplemental oxygen strategies in infants with bronchopulmonary dysplasia after the neonatal intensive care unit period: study protocol for a randomised controlled trial (SOS BPD study)
BMJ Open
title Supplemental oxygen strategies in infants with bronchopulmonary dysplasia after the neonatal intensive care unit period: study protocol for a randomised controlled trial (SOS BPD study)
title_full Supplemental oxygen strategies in infants with bronchopulmonary dysplasia after the neonatal intensive care unit period: study protocol for a randomised controlled trial (SOS BPD study)
title_fullStr Supplemental oxygen strategies in infants with bronchopulmonary dysplasia after the neonatal intensive care unit period: study protocol for a randomised controlled trial (SOS BPD study)
title_full_unstemmed Supplemental oxygen strategies in infants with bronchopulmonary dysplasia after the neonatal intensive care unit period: study protocol for a randomised controlled trial (SOS BPD study)
title_short Supplemental oxygen strategies in infants with bronchopulmonary dysplasia after the neonatal intensive care unit period: study protocol for a randomised controlled trial (SOS BPD study)
title_sort supplemental oxygen strategies in infants with bronchopulmonary dysplasia after the neonatal intensive care unit period study protocol for a randomised controlled trial sos bpd study
url https://bmjopen.bmj.com/content/12/7/e060986.full
work_keys_str_mv AT antonhvankaam supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT wesonland supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT irwinkmreiss supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT peterhdijk supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT arendfbos supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT elenirosalinaandrinopoulou supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT evillamor supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT lgmvanrooij supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT mdejong supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT jsvonlindern supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT lucasgoossens supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT stephaniebalink supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT eliannejlevrijlandt supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT anthonrhulsmann supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT debbiehnuytemans supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT arwenjsprij supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT andreakroon supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT mariellepijnenburg supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT mgabaartmans supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT gjblok supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT wpdeboode supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT hdbuiter supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT cecounsilman supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT cadalenmeurs supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT acmdassel supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT amdegrauw supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT menvandenheuvel supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT jlamvanhillegersberg supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT jcrvanhoften supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT jhlvanhoorn supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT chtenhove supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT akamerbeek supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT aamwvankempen supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT lhvandermeer supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT rmjmoonen supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT eemmulder supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT hjniemarkt supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT magvanscherpenzeeldevries supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT iamschiering supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy
AT rngbtan supplementaloxygenstrategiesininfantswithbronchopulmonarydysplasiaaftertheneonatalintensivecareunitperiodstudyprotocolforarandomisedcontrolledtrialsosbpdstudy